-
Beyond the QALY: An Analysis of Uncaptured Benefits in NICE Oncology Technology Appraisals 2023-2025
Sep 9, 2025, 16:22 PM -
Healthcare Costs in Older Adults: XGBoost, NNA, and Logit
Sep 9, 2025, 16:22 PM -
Impact Of Dupilumab Treatment on Work-Related Medical Leave In Patients With Atopic Dermatitis in a Colombian Health Insurance Provider: An Observational Real-World Practice Study
Sep 9, 2025, 16:22 PM -
Care of Patients With Phenylketonuria (PKU) in Germany a Claims Data Analysis From 2013 to 2023
Sep 9, 2025, 16:22 PM -
Patient Preferences in Gene Therapy Development for Arrhythmogenic Cardiomyopathy: The UR-HEART Qualitative Study
Sep 9, 2025, 16:22 PM -
Balancing Cost-Effectiveness With Societal Values: A Representative Survey of Norwegian Attitudes Toward Healthcare Resource Allocation
Sep 9, 2025, 16:22 PM -
Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to UAE EQ-5D-5L Valuations
Sep 9, 2025, 16:22 PM -
Signal Detection and Network Pharmacology Analysis of Paronychia Associated With eGFR Inhibitors
Sep 9, 2025, 16:22 PM -
Medium vs. Low Citrate Concentration in Continuous Kidney Replacement Therapy: Positive Budget Impact Through Total Cost of Ownership Assessment
Sep 9, 2025, 16:22 PM -
Economic and Epidemiological Burden of Type 1 Diabetes In France
Sep 9, 2025, 16:22 PM -
Exploring Value in Healthcare: Patient Satisfaction in Spain Before and After the Pandemic
Sep 9, 2025, 16:22 PM -
Differential Responsiveness and Minimally Important Difference of EQ-5D: Truth or Artifact?
Sep 9, 2025, 16:22 PM -
Life-Years Lost Due to Regulatory and Reimbursement Delays: A Study of Oncology Drugs Across England, Scotland, and France, 2022-2024
Sep 9, 2025, 16:22 PM -
The Elusive PICO: Assessing Prediction in Joint Clinical Assessments (JCA): A Case Study in Soft Tissue Sarcoma (STS)
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Adults With Dry Eye Disease in France: Insights From a Multicenter Observational Study
Sep 9, 2025, 16:22 PM -
Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS
Sep 9, 2025, 16:22 PM -
What Are the Likely PICOs for Tovorafenib and Lifileucel as the First Products to Go Through the JCA?
Sep 9, 2025, 16:22 PM -
A Comparative Analysis of Early Access Pathways in Italy and France: Law 64896 vs. the French AAP
Sep 9, 2025, 16:22 PM -
Patient Access Delays in Multi-Indication Medicines: A Review of Health Technology Assessment Timelines
Sep 9, 2025, 16:22 PM -
Integrating Prospective and Retrospective Real-World Data to Construct External Comparator Arms: Novel Methods and Design Considerations
Sep 9, 2025, 16:22 PM
